(Q34316613)

English

Osteogenesis imperfecta

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Osteogenesis imperfecta. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

osteogenesis imperfecta

0 references

author name string

Frank Rauch

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Francis H Glorieux

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

363

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

9418

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1377-1385

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Scanning electron microscopy of teeth in osteogenesis imperfecta type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dental aberrations in children and adolescents with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hearing loss in patients with osteogenesis imperfecta. A clinical and audiological study of 201 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hearing loss in children with osteogenesis imperfecta.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

How common is hearing impairment in osteogenesis imperfecta?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hearing loss in Finnish adults with osteogenesis imperfecta: a nationwide survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-a

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Testing for osteogenesis imperfecta in cases of suspected non-accidental injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic heterogeneity in osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Type V osteogenesis imperfecta: a new form of brittle bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Causes of death in osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Life expectancy in osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperplastic callus formation in osteogenesis imperfecta: CT and MRI findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

MRI and CT features of hyperplastic callus in osteogenesis imperfecta tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta type VII maps to the short arm of chromosome 3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bruck syndrome (osteogenesis imperfecta with congenital joint contractures): review and report on the first North American case

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Panostotic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin deficiency and juvenile Paget's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone fragility, craniosynostosis, ocular proptosis, hydrocephalus, and distinctive facial features: a newly recognized type of osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The ocular form of osteogenesis imperfecta: a new autosomal recessive syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Idiopathic juvenile osteoporosis: experience of twenty-one patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging of child abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone density measurements by computed tomography in osteogenesis imperfecta type I

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Collagen fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta: perspectives and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Killing the messenger: new insights into nonsense-mediated mRNA decay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Procollagen with skipping of alpha 1(I) exon 41 has lower binding affinity for alpha 1(I) C-telopeptide, impaired in vitro fibrillogenesis, and altered fibril morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related changes in human bone proteoglycan structure. Impact of osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The mineralization density of iliac crest bone from children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The Material Basis for Reduced Mechanical Properties in oim Mice Bones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Static and dynamic bone histomorphometry in children with osteogenesis imperfecta.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta in childhood: treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta in childhood: impairment and disability--a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of withdrawal of bracing in matched pairs of children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical stabilisation of the lower limb in osteogenesis imperfecta using the Sheffield Telescopic Intramedullary Rod System

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with Bailey-Dubow rodding in children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Is APD a promising drug in the treatment of severe osteogenesis imperfecta?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous pamidronate treatment in osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid Increase in Grip Force After Start of Pamidronate Therapy in Children and Adolescents With Severe Osteogenesis Imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta and intravenous pamidronate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous neridronate in adults with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiographic features of bisphosphonate therapy in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous bisphosphonate therapy in children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of children with Osteogenesis imperfecta in Estonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates in children with osteogenesis imperfecta may improve bone mineralization but not bone strength. Report of two patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's law: the bone modeling problem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's law: the remodeling problem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta after the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates: from grandparents to grandchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonate-induced osteopetrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural Development of the Mineralized Tissue in the Human L4 Vertebral Body

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted and nontargeted remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

On an Attempt to Treat Primary and Secondary Osteoporosis with Human Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of growth hormone treatment on calcium kinetics in patients with osteogenesis imperfecta type III and IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human parathyroid hormone. Preclinical data on rat osteosarcoma were not dismissed

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Marrow stromal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells: no longer second class marrow citizens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta calls for caution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta calls for caution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe osteogenesis imperfecta: new therapeutic options?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteogenesis imperfecta: prospects for molecular therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Delivery of a hammerhead ribozyme specifically downregulates mutant type I collagen mRNA in a murine model of osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The chemical repertoire of natural ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916051-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)16051-0

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34316613&oldid=1547088404"